ijms-logo

Journal Browser

Journal Browser

Advances in Sepsis: Pathogenesis, Biomarkers, Treatments and Prognosis

Special Issue Editor


E-Mail
Guest Editor
High-Dependency Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Careggi, Lg. Brambilla 3, 50134 Firenze, Italy
Interests: sepsis; sepsis-induced cardiomyopathy; sepsis treatment; non-invasive ventilation; simulation; education

Special Issue Information

Dear Colleagues,

I am delighted to present this new IJMS Special Issue, collecting new developments in sepsis diagnosis and treatment.

In 2024, we are still discussing sepsis, even though we all know that it is not a single disease. Indeed, previous comorbidities, infection sources, and causative pathogens influence its development, evolution, and response to treatment, as well as the final prognosis. We need to improve our ability to characterize septic patients from several points of view.

First, we must learn to better recognize sepsis early to prompt the best treatment. New feasible and reliable biomarkers need to be validated with robust scientific evidence. It is also urgent to find the correct and meaningful application of new technologies for early bacterial identification. This would help us reduce the employment of empiric antibiotic treatments, a cornerstone in the fight against the growing spectrum of antimicrobial resistance. Similarly, we must overcome the “one-size-fits-all” approach that has guided the early resuscitation of septic patients until now. Meanwhile, an inadequate selection of study populations might explain the non-significant results obtained by several studies, which evaluated novel regimens of fluid administration or vasopressor dosing and timing without ascertaining whether the right patient was assigned to the right study arm. Improved characterization will translate into better prognostic assessment and early identification of patients at high risk of an adverse prognosis.

Importantly, contributions should focus on some molecular aspects but must not include only pure clinical research.

Dr. Francesca Innocenti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • sepsis phenotypes
  • hemodynamic stabilization
  • fluids
  • vasopressors
  • diagnostic biomarkers
  • tailored approach
  • immune modulation
  • immunomodulatory therapy
  • prognostic stratification

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop